Coronavirus Pandemic – PFIZER AND BIONTECH CHOOSE LEAD MRNA VACCINE CANDIDATE AGAINST COVID-19 AND COMMENCE PIVOTAL PHASE 2/3 GLOBAL STUDY
Green Cross Strong news - New York, NY: Pfizer Inc. reports Companies advance nucleoside-modified messenger RNA (modRNA) candidate BNT162b2, which encodes an optimized SARS-CoV-2 full-length spike glycoprotein, at a 30µg dose level in a 2 dose regimen into Phase 2/3 StudyCandidate and dose level selection informed by preclinical and clinical data obtained in Phase 1/2 studies conducted in the (C4591001) and Germany (BNT162-01) The Phase 2/3…
Coronavirus Pandemic – PFIZER AND BIONTECH ANNOUNCE AN AGREEMENT WITH U.S. GOVERNMENT FOR UP TO 600 MILLION DOSES OF MRNA-BASED VACCINE CANDIDATE AGAINST SARS-COV-2
Green Cross Strong news - New York, NY: Pfizer Inc. reports government placed an initial order of 100 million doses for $ billion and can acquire up to 500 million additional doses. Americans to receive the vaccine for free consistent with government’s commitment for free access for COVID-19 vaccines. Pfizer and BioNTech remain on track to begin an anticipated Phase 2b/3 safety and efficacy trial…
President Donald J. Trump Is Taking Action to Lower Drug Costs and Ensure That Americans Have Access to Life-saving Medications
Green Cross Strong news - Washington, DC: The White House reports " Since the day I took office, I have made reducing drug prices one of my highest priorities. " President Donald J. Trump. EXPANDING ACCESS TO LIFE-SAVING DRUGS: President Donald J. Trump is taking action to greatly improve the affordability and accessibility of life-saving prescription drugs. President Trump signed four Executive Orders to massively…
Access to Affordable Life-saving Medications
Green Cross Strong news - Washington, DC: The White House reports Executive Order by The President. By the authority vested in me as President by the Constitution and the laws of the United States of America, it is hereby ordered as follows: Section ; ; Insulin is a critical and life-saving medication that approximately 8 million Americans rely on to manage diabetes. Likewise, injectable epinephrine is a life‑saving medication used to…
Coronavirus Pandemic – Pfizer to produce and deliver 100 million doses of their COVID-19 vaccine
Green Cross Strong news - Washington, DC: The White House reports Remarks by President Trump in Press Briefing. James S. Brady Press Briefing Room. 5:50 EDT THE PRESIDENT: Thank you very ; Thank ; Today, my administration reached a historic agreement with Pfizer to produce and deliver 100 million doses of their vaccine immediately following its ; Hopefully, the approval process will go very ;…
Continuation of U.S. Drug Interdiction Assistance to the Government of Colombia
US Strong news - Washington, DC: The White House reports MEMORANDUM FOR THE SECRETARY OF STATETHE SECRETARY OF DEFENSE SUBJECT: Continuation of Drug InterdictionAssistance to the Government of Colombia By the authority vested in me as President by the Constitution and the laws of the United States, and pursuant to the authority vested in me by section 1012 of the National Defense Authorization Act for Fiscal…
President Trump on SOUTHCOM Enhanced Counternarcotics Operations
US Strong news – Washington, DC: The White House reports Southern Command – Doral, Florida 1:28 EDT. THE PRESIDENT: Thank you very much, ; Thank you very ; (Applause.) And thank you to our great Admiral ; Thank you also to all of the exceptional leaders and talents that we have in this ; Southern Command is just an outstanding group of ; Thank you…
Scientists develop new medical cannabis cultivars that show promise in combating COVID-19 virus
Green Cross Strong news - Lethbridge, Alberta Canada: University of Lethbridge reports In partnership with the University of Lethbridge, Pathway RX, a research company focused on developing custom cannabis therapies, and Swysh, a company focused on cannabinoid research and development, have found that specific Cannabis sativa extracts show promise as an additional treatment for COVID-19. “While our most successful extracts require further validation in a large-scale…